GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Megasoft Ltd (NSE:MEGASOFT) » Definitions » Research & Development

Megasoft (NSE:MEGASOFT) Research & Development : ₹0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Megasoft Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Megasoft's Research & Development for the three months ended in Jun. 2024 was ₹0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was ₹0.00 Mil.

Megasoft Research & Development Historical Data

The historical data trend for Megasoft's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Megasoft Research & Development Chart

Megasoft Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Megasoft Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Megasoft Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Megasoft  (NSE:MEGASOFT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Megasoft Research & Development Related Terms

Thank you for viewing the detailed overview of Megasoft's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Megasoft Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Megasoft Ltd (NSE:MEGASOFT) » Definitions » Research & Development
Comparable Companies
BOM:524654 BOM:541096 BOM:530477 BOM:539997 BOM:500009 BOM:526953 NSE:MADHAVBAUG BOM:524212 BOM:524731 BOM:533543 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
532408:India
Address
Image Gardens Road, 8th Floor, Unit No. 801B, Plot No. 1, 28 & 29, 98/4/1 to 13, Jain Sadguru Image’s Capital Park, Madhapur, Hyderabad, TG, IND, 500081
Website
http://www.megasoft.com
Megasoft Ltd is focused on Pharma, Aerospace and Defense Electronics areas and is in the process of acquiring a few companies and intends to provide centralized corporate, technology, finance, and leadership/management support services to such subsidiaries/associate companies. The company has invested in Extrovis AG, a company engaged in Pharmaceutical R&D and in the business of development, production, distribution and sale of chemicals and pharmaceuticals of all kinds has a wide range of activities aimed at bringing safe, effective, and high-quality drugs to the market.

Megasoft Headlines

No Headlines